Research has shown that IgA and IgM antibody levels decline rapidly following a SARS-CoV-2 infection, while IgG levels rise and remain steady for at least four to six months after the infection (Gudbjartsson et al., 2020; Isho et al., 2020; L’Huillier et al., 2021). This evidence concerns the gene CD79A and infection.